Adicet Bio, Inc. (ACET) vs Connect Biopharma Holdings Limited (CNTB)
A side-by-side comparison of Adicet Bio, Inc. and Connect Biopharma Holdings Limited across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
ACET
Adicet Bio, Inc.
$6.52HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
CNTB
Connect Biopharma Holdings Limited
$0.96HealthcareDelayed quote: Oct 6, 2026, 11:25 AM EDT
Total return — ACET vs CNTB
growth of $100 · dividends reinvested · last 6yACET -97.3% (-45.4%/yr)CNTB -95.1% (-39.6%/yr)CNTB compounded faster over this window
ACET CNTB
ACET vs CNTB: by the numbers
- •ACET is the larger company ($61M vs $60M market cap).
- •Both run net losses; ACET's is the smaller (0.00% vs -86687.50% net margin).
Metrics side by side
Valuation
| Metric | ACET | CNTB |
|---|---|---|
| P/B ratio | 0.51 | 2.24 |
Profitability
| Metric | ACET | CNTB |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -90740.62% |
| Net margin | 0.00% | -86687.50% |
| ROE | -82.38% | -132.16% |
| ROIC | -79.68% | -136.77% |
Growth (annualized)
| Metric | ACET | CNTB |
|---|---|---|
| Total return CAGR (5Y) | -44.24% | -47.22% |
Frequently asked
- How have ACET and CNTB total returns compared?
- Over the past 5 years, ACET delivered -44.24% and CNTB delivered -47.22% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.